Clinical Trial Update: Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study [Phase 2]

View source ↗

Summary

This update describes a Phase 2 single-arm clinical study evaluating nebulized recombinant human p53 adenovirus injection for multiple ground-glass lung nodules…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasms
• Precancerous Conditions

Drugs mentioned

• Nebulized recombinant human p53 adenovirus (recombinant human p53 adenovirus)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Multiple Pulmonary Ground-Glass Nodules, Lung Neoplasms | Phase 2 | Status: NOT_YET_RECRUITING